QR code

Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China

Background: Lopinavir/ritonavir (LPV/r) is a major antiretroviral treatment in China, but little is known about the performance of first-line LPV/r-based regimen in treatment-naïve patients with human immunodeficiency virus type 1 (HIV-1) infection. This study aims to assess the efficacy and adverse...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Bin Su, Yin Wang, Ruifeng Zhou, Taiyi Jiang, Hongwei Zhang, Zaicun Li, An Liu, Ying Shao, Wei Hua, Tong Zhang, Hao Wu, Shenghua He, Lili Dai, Lijun Sun
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2019-12-01
Reeks:Frontiers in Pharmacology
Onderwerpen:
human immunodeficiency virus
first-line therapy
antiretroviral therapy
lopinavir/ritonavir
efavirenz
adverse effects
Online toegang:https://www.frontiersin.org/article/10.3389/fphar.2019.01472/full
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items